Acciones Neovasc Inc.
Acciones
NVCN
CA64065J4037
Equipo médico y tecnología avanzada
Directores | Puesto | Edad | Desde |
---|---|---|---|
Sarah Gallagher
CTO | Chief Tech/Sci/R&D Officer | - | 13/07/21 |
Shmuel Banai
CTO | Chief Tech/Sci/R&D Officer | - | - |
Alexei J. Marko
BRD | Director/Board Member | 56 | 12/06/03 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Steven Rubin
CHM | Chairman | 63 | 01/02/08 |
Paul Geyer
BRD | Director/Board Member | 61 | 02/11/00 |
Alexei J. Marko
BRD | Director/Board Member | 56 | 12/06/03 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+8,07 % | 219 mil M | |
+6,59 % | 183 mil M | |
+11,26 % | 133 mil M | |
+26,57 % | 108 mil M | |
+0,65 % | 63,06 mil M | |
+13,35 % | 52,02 mil M | |
-0,62 % | 48,2 mil M | |
-0,93 % | 40,37 mil M | |
+11,54 % | 39,35 mil M |